Mixing Biometric Data For Generating Joint Identities and Preserving Privacy

Biometrics is the science of automatically recognizing individuals by utilizing biological traits such as fingerprints, face, iris and voice. A classical biometric system digitizes the human body and uses this digitized identity for human recognition. In this work, we introduce the concept of mixing biometrics. Mixing biometrics refers to the process of generating a new biometric image by fusing images of different fingers, different faces, or different irises. The resultant mixed image can be used directly in the feature extraction and matching stages of an existing biometric system. In this regard, we design and systematically evaluate novel methods for generating mixed images for the fingerprint, iris and face modalities. Further, we extend the concept of mixing to accommodate two distinct modalities of an individual, viz., fingerprint and iris. The utility of mixing biometrics is demonstrated in two different applications. The first application deals with the issue of generating a joint digital identity. A joint identity inherits its uniqueness from two or more individuals and can be used in scenarios such as joint bank accounts or two-man rule systems. The second application deals with the issue of biometric privacy, where the concept of mixing is used for de-identifying or obscuring biometric images and for generating cancelable biometrics. Extensive experimental analysis suggests that the concept of biometric mixing has several benefits and can be easily incorporated into existing biometric systems

SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study

Background: Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling. Methods: The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on postoperative SARS-CoV-2 rates and mortality in an international cohort study (surgical patients), and community SARS-CoV-2 incidence and case fatality data (general population). NNV estimates were stratified by age (18-49, 50-69, 70 or more years) and type of surgery. Best- and worst-case scenarios were used to describe uncertainty. Results: NNVs were more favourable in surgical patients than the general population. The most favourable NNVs were in patients aged 70 years or more needing cancer surgery (351; best case 196, worst case 816) or non-cancer surgery (733; best case 407, worst case 1664). Both exceeded the NNV in the general population (1840; best case 1196, worst case 3066). NNVs for surgical patients remained favourable at a range of SARS-CoV-2 incidence rates in sensitivity analysis modelling. Globally, prioritizing preoperative vaccination of patients needing elective surgery ahead of the general population could prevent an additional 58 687 (best case 115 007, worst case 20 177) COVID-19-related deaths in 1 year. Conclusion: As global roll out of SARS-CoV-2 vaccination proceeds, patients needing elective surgery should be prioritized ahead of the general population